Literature DB >> 3596017

The chicken thymidine kinase gene is transcriptionally repressed during terminal differentiation: the associated decline in TK mRNA cannot account fully for the disappearance of TK enzyme activity.

M K Gross, M S Kainz, G F Merrill.   

Abstract

Thymidine kinase (TK) is representative of a class of enzymes involved in DNA precursor biosynthesis that declines as cells withdraw from the cell cycle. If TK activity is regulated exclusively by the availability of messenger RNA, changes in enzyme activity levels should not precede or excede changes in TK mRNA levels. This prediction was tested in several tissues during chicken embryogenesis and in differentiating muscle cells in culture. A sensitive method of determining absolute TK mRNA levels was developed. A synthetic complimentary RNA probe spanning an intron acceptor site in the chicken TK gene was hybridized with cellular RNA or synthetic colinear TK RNA of known concentration. After RNase digestion and gel electrophoresis, the intensity of the protected fragment was used to calculate absolute TK mRNA levels. As few as 0.02 molecules of TK mRNA per cell could be measured accurately. Depending on the tissue type, 8-day embryos contained between 3 and 12 TK mRNAs per cell. Proliferating mouse muscle cells transformed with the chicken TK gene contained between 30 and 150 TK mRNAs per cell. Both in vivo and in vitro, TK mRNA levels declined as cells withdrew from the cell cycle during differentiation. In vivo, the decline in TK activity never preceded or exceeded observed changes in TK mRNA. However, in the cell culture system, TK activity consistently declined to a greater extent than TK mRNA. Thus, a translational or a post-translational mechanism must also be operative in controlling TK activity levels. Estimation of transcription rates in nuclei isolated from proliferating and differentiated muscle cell transformants indicated that the TK gene was transcriptionally repressed in postreplicative cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596017     DOI: 10.1016/0012-1606(87)90308-3

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  8 in total

1.  Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors.

Authors:  Y K Kim; A S Lee
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Clonal derivation of a rat muscle cell strain that forms contraction-competent myotubes.

Authors:  G F Merrill
Journal:  In Vitro Cell Dev Biol       Date:  1989-05

3.  Thymidine kinase synthesis is repressed in nonreplicating muscle cells by a translational mechanism that does not affect the polysomal distribution of thymidine kinase mRNA.

Authors:  M K Gross; G F Merrill
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Introns are inconsequential to efficient formation of cellular thymidine kinase mRNA in mouse L cells.

Authors:  M K Gross; M S Kainz; G F Merrill
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

5.  Regulation of thymidine kinase protein levels during myogenic withdrawal from the cell cycle is independent of mRNA regulation.

Authors:  M K Gross; G F Merrill
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

6.  Changes in dihydrofolate reductase (DHFR) mRNA levels can account fully for changes in DHFR synthesis rates during terminal differentiation in a highly amplified myogenic cell line.

Authors:  E E Schmidt; G F Merrill
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

7.  Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.

Authors:  R B Tenser; A Gaydos; K A Hay
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Maintenance of dihydrofolate reductase enzyme after disappearance of DHFR mRNA during muscle cell differentiation.

Authors:  E E Schmidt; G F Merrill
Journal:  In Vitro Cell Dev Biol       Date:  1989-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.